Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment
- PMID: 15862937
- DOI: 10.1016/j.gtc.2005.02.009
Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment
Abstract
Several twin studies and familial aggregation studies in IBS are consistent with either a genetic or a social learning hypothesis, and it is possible that both play a role. The prospect of identifying a genetic cause for IBS may be very important, because it raises the possibility of confirming that IBS isa disease entity, suggests new insight into the pathophysiology of the disorder, and provides new targets for drug development. Several candidate genetic markers including: those related to cytokines such as IL-10, TNF-alpha and TGF beta1; SERT-P; alpha-adrenergic receptors; and G proteins have been associated with certain aspects of IBS. Genetic polymorphisms,however, are common and may have no etiological or pathogenetic relevance. Searching for the genes in IBS is of potentially great relevance. Such studies may identify more specific phenotypes in IBS or potentially predict increased disease vulnerability, but it is unlikely that this strategy will lead to a diagnostic test, given the limited component of IBS that is likely to be genetically determined. Pharmaco genomic studies have potential to be important in the future. For this potential to be realized, it will be necessary to formally include genetic studies in trials of experimental drugs.This would enhance understanding of one of the roles of genetics for treating IBS.
Similar articles
-
Serotonin transporter gene polymorphism and irritable bowel syndrome.Neurogastroenterol Motil. 2006 Nov;18(11):995-1000. doi: 10.1111/j.1365-2982.2006.00829.x. Neurogastroenterol Motil. 2006. PMID: 17040410
-
[Genetic background of irritable bowel syndrome].Orv Hetil. 2006 Jun 25;147(25):1167-70. Orv Hetil. 2006. PMID: 16893132 Review. Hungarian.
-
Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.Am J Gastroenterol. 2005 Nov;100(11):2510-6. doi: 10.1111/j.1572-0241.2005.00257.x. Am J Gastroenterol. 2005. PMID: 16279907
-
Association of alpha 2A adrenergic receptor gene (ADRAlpha2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis.Clin Chim Acta. 2010 Jan;411(1-2):59-63. doi: 10.1016/j.cca.2009.10.003. Epub 2009 Oct 13. Clin Chim Acta. 2010. PMID: 19833115
-
Is there a SERT-ain association with IBS?Gut. 2004 Oct;53(10):1396-9. doi: 10.1136/gut.2004.039826. Gut. 2004. PMID: 15361483 Free PMC article. Review. No abstract available.
Cited by
-
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.Dig Dis Sci. 2013 Aug;58(8):2314-23. doi: 10.1007/s10620-013-2677-y. Epub 2013 Apr 18. Dig Dis Sci. 2013. PMID: 23595519
-
Guidelines on the irritable bowel syndrome: mechanisms and practical management.Gut. 2007 Dec;56(12):1770-98. doi: 10.1136/gut.2007.119446. Epub 2007 May 8. Gut. 2007. PMID: 17488783 Free PMC article. Review.
-
Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders.J Neurogastroenterol Motil. 2018 Jul 30;24(3):367-386. doi: 10.5056/jnm18071. J Neurogastroenterol Motil. 2018. PMID: 29969855 Free PMC article. Review.
-
The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients.Dig Dis Sci. 2007 Nov;52(11):2942-9. doi: 10.1007/s10620-006-9679-y. Epub 2007 Mar 30. Dig Dis Sci. 2007. PMID: 17394071 Clinical Trial.
-
Investigation of esophageal sensation and biomechanical properties in functional chest pain.Neurogastroenterol Motil. 2010 May;22(5):520-6, e116. doi: 10.1111/j.1365-2982.2009.01451.x. Epub 2010 Jan 12. Neurogastroenterol Motil. 2010. PMID: 20067548 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources